{
  "report_rows": [
    {
      "kpi": "Q2 2026 total revenue",
      "prediction": "BEAT",
      "answer": "pred ~$3.71B vs. cons $3.66B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.63 vs. cons $0.61",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$1.06B vs. cons $1.03B",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Total revenue guidance",
      "prediction": "BETTER",
      "answer": "guide ~$14.80B midpoint vs. cons $14.78B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA guidance",
      "prediction": "BETTER",
      "answer": "guide ~$4.42B midpoint vs. cons $4.39B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$2.49 vs. cons $2.47 (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.3,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.9,
  "day5_path": "FADE",
  "day5_rationale": "A modest Q2 beat and FY2026 guide slightly above consensus should drive an initially positive reaction, but the implied H2 adjusted EPS requirement of ~$1.27 versus consensus ~$1.27 leaves little room for upward revisions; higher launch and R&D spending should fade part of the day-1 gain.",
  "day5_confidence": "MEDIUM"
}